COMMUNIQUÉS West-GlobeNewswire

Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP

11/05/2018 - 14:30

– ABP HOLDS FIRST & ONLY CANNABIS LICENSE IN ARGENTINA – – ABP REVENUES IN EXCESS OF USD$11 MILLION IN 2017 AND PROFITABLE – TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or [...]

T1D Exchange Co-Founder Dana Ball to Step Down as CEO

11/05/2018 - 14:30

Will Continue His Long-Time Patient Advocacy Career as a Member of the Board BOSTON, May 11, 2018 (GLOBE NEWSWIRE) -- T1D Exchange , a patient-centered research organization dedicated to accelerating therapies and [...]

Cerner to Hold 2018 Shareholder Meeting May 18

11/05/2018 - 14:30

KANSAS CITY, Mo., May 11, 2018 (GLOBE NEWSWIRE) -- Cerner is hosting its annual Shareholder Meeting on May 18, 2018. The meeting will begin at 10 a.m. CT and an audio webcast will be available on Cerner’s website in the [...]

Progressive Care Inc. Selects CMW Media as New Public Relations Agency of Record

11/05/2018 - 14:30

MIAMI, May 11, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare technology services organization and provider of prescription pharmaceuticals, compounded medications and tele-pharmacy services, [...]

Cerecor Reports First Quarter 2018 Financial Results

11/05/2018 - 14:15

BALTIMORE, May 11, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC ) (“Cerecor” or the “Company”) today announced financial results for the first quarter of 2018. Net revenues for the first quarter of 2018 were $4.5 [...]

Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights

11/05/2018 - 14:15

Investor Conference Call on Monday, May 14th at 10:00 am ET NEW YORK and CLEVELAND, May 11, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused [...]

Vital Therapies to Host Analyst R&D Day on May 24, 2018

11/05/2018 - 14:01

SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will host a live [...]

Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results

11/05/2018 - 14:00

MADISON, Wis., May 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

Samumed Announces Presentation at the 2018 American Thoracic Society (ATS) International Conference

11/05/2018 - 14:00

SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt signaling pathway research and development, today announced it will present preclinical data on the company’s investigational Wnt pathway [...]

Denali Therapeutics Reports First Quarter 2018 Financial Results

11/05/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., May 11, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, [...]

Spectral Announces First Quarter Results

11/05/2018 - 14:00

TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]

Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th

11/05/2018 - 14:00

AUSTIN, Texas, May 11, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ: SVRA ), an orphan lung disease company, announced today that the Company's Chief Executive Officer, Rob Neville, will present at the Bank of America [...]

Theratechnologies Announces That National Institutes of Health Will Support Study on EGRIFTA® (Tesamorelin for Injection) in Non-HIV Patients With Non-Alcoholic Fatty Liver Disease

11/05/2018 - 14:00

MONTREAL, May 11, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today announced that the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) in the [...]

Theratechnologies annonce que les National Institutes of Health appuieront une étude avec EGRIFTA(MD) (tésamoréline pour injection) chez des patients séro-négatifs atteints de stéatose hépatique non alcoolique

11/05/2018 - 14:00

MONTRÉAL, 11 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) a annoncé aujourd’hui today que le National Institute of Diabetes and Digestive and Kidney Diseases des National Institutes of Health (NIH) aux [...]

Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance

11/05/2018 - 14:00

Part of Strong Company Presence at 2018 MAD-ID Annual Meeting NEW HAVEN, Conn., May 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and [...]

Celsion Corporation Reports First Quarter 2018 Financial Results and Provides Business Update

11/05/2018 - 14:00

Significant Progress in Phase III Liver Cancer and Phase I/II Ovarian Cancer Studies Supported with Solid Fundamentals and a Strong Balance Sheet Company to Hold Conference Call on Friday, May 11, 2018 at 11:00 a.m. EDT [...]

Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update

11/05/2018 - 14:00

ATLANTA, GA and BOTHELL, WA, May 11, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference

11/05/2018 - 13:34

LONDON, May 11, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq: HCM ) announced today that Christian Hogg, Chief Executive Officer, will present at the Bank of America Merrill [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

11/05/2018 - 13:31

FIT Biotech Oy Company release May 11, 2018 at 2.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]